Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

TIMI-AF score and cardiovascular events in vitamin K antagonists-naïve outpatients with atrial fibrillation.

Pérez Cabeza AI, Bravo Marques R, Chinchurreta Capote PA, Ruiz Mateas F, Fanola CL, Rosas Cervantes G, González Correa JA, Valle Alberca A, Mesa Prado F, López Tejero S, Ruff CT.

Clin Cardiol. 2018 Sep;41(9):1252-1258. doi: 10.1002/clc.23035. Epub 2018 Aug 20.

2.

Drug persistence and outcomes in a cohort of patients with nonvalvular atrial fibrillation treated with rivaroxaban after 2 years of follow-up in clinical practice.

Pérez Cabeza AI, González Correa JA, Chinchurreta Capote PA, Bravo Marqués R, Ruiz Mateas F, Rosas Cervantes G, Mesa Prado F, López Tejero S, Valle Alberca A.

Future Cardiol. 2018 May;14(3s):9-16. doi: 10.2217/fca-2018-0021.

PMID:
29848094
3.

Direct Oral Anticoagulants Versus Vitamin K Antagonists in Real-life Patients With Atrial Fibrillation. A Systematic Review and Meta-analysis.

Escobar C, Martí-Almor J, Pérez Cabeza A, Martínez-Zapata MJ.

Rev Esp Cardiol (Engl Ed). 2019 Apr;72(4):305-316. doi: 10.1016/j.rec.2018.03.009. Epub 2018 Mar 30. English, Spanish.

PMID:
29606361
4.

Discrepancies between the use of MDRD-4 IDMS and CKD-EPI equations, instead of the Cockcroft-Gault equation, in the determination of the dosage of direct oral anticoagulants in patients with non-valvular atrial fibrillation.

Pérez Cabeza AI, Chinchurreta Capote PA, González Correa JA, Ruiz Mateas F, Rosas Cervantes G, Rivas Ruiz F, Valle Alberca A, Bravo Marqués R.

Med Clin (Barc). 2018 Feb 9;150(3):85-91. doi: 10.1016/j.medcli.2017.06.003. Epub 2017 Jul 22. English, Spanish.

PMID:
28739270
5.

Newly impaired glucose metabolism and prognosis after percutaneous revascularization.

Jiménez-Navarro MF, Fernández-Pastor J, Garrido-Sánchez L, Molina-Mora MJ, Ortiz-García C, Alonso-Briales JH, Pérez-Cabeza A, Hernández-García JM, de Teresa-Galván E, Tinahones FJ.

Cardiol J. 2015;22(1):44-51. doi: 10.5603/CJ.a2014.0024. Epub 2014 Mar 27.

PMID:
24671899
6.

Poor reproducibility of the oral glucose tolerance test in the diagnosis of diabetes during percutaneous coronary intervention.

Jiménez-Navarro MF, Garcia-Pinilla JM, Garrido-Sanchez L, Alonso-Briales JH, Pérez-Cabeza A, Ortiz-García C, Hernández-Garcia JM, Tinahones F, de Teresa E.

Int J Cardiol. 2010 Jul 23;142(3):245-9. doi: 10.1016/j.ijcard.2009.01.020. Epub 2009 Feb 20.

PMID:
19232754
7.

[Multidetector computed tomography of the coronary veins and resynchronization therapy].

Flores Y, Pérez-Cabeza A, Leta R.

Rev Esp Cardiol. 2006 Oct;59(10):1070. Spanish. No abstract available.

8.

[Systolic ventricular dysfunction, a new marker of coronary artery disease in patients with aortic stenosis without previous myocardial infarction].

Pérez Cabeza AI, Gómez Doblas JJ, Morcillo Hidalgo L, Cabrera Bueno F, Jiménez Navarro MF, López Salguero R, Rodríguez Bailón I, de Teresa Galván E.

Rev Esp Cardiol. 2005 Feb;58(2):218-21. Spanish.

9.

[Dynamic left ventricular outflow tract obstruction induced by exercise].

Cabrera Bueno F, Rodríguez Bailón I, López Salguero R, Gómez Doblas JJ, Pérez Cabeza A, Peña Hernández J, Domínguez Franco A, Morcillo Hidalgo L, de Teresa Galván E.

Rev Esp Cardiol. 2004 Dec;57(12):1179-87. Spanish.

Supplemental Content

Loading ...
Support Center